Quinolone resistance in enterotoxigenic Escherichia coli causing diarrhea in travelers to India in comparison with other geographical areas

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 6, 2000, Pages 1731-1733

  Vila, Jordi ^a   Vargas, Martha ^a   Ruiz, Joaquim ^a   Corachan, Manuel ^a   De Anta, M Teresa Jimenez ^a   Gascon, Joaquim ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ESCHERICHIA COLI ENTEROTOXIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM ISOLATE; DRUG EFFICACY; GEOGRAPHIC DISTRIBUTION; INDIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TRAVELLER DIARRHEA;

DIARRHEA; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; INDIA; QUINOLONES;

EID: 0034036550     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.6.1731-1733.2000     Document Type: Article

References (18)

1. Black, R. E., M. M. Levine, M. L. Clements, L. Cisneros, and V. Daya. 1982. Treatment of experimental induced enterotoxigenic Escherichia coli diarrhea with trimethoprim, trimethoprim-sulfamethoxazole, or placebo. Rev. Infect. Dis. 4:540-545.
2. DuPont, H. L., R. R. Reves, E. Galindo, P. S. Sullivan, L. V. Wood, and J. G. Mediola. 1982. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N. Engl. J. Med. 307:841-844.
3. DuPont, H. L., C. D. Ericsson, J. J. Mathewson, and M. W. DuPont. 1992. Five versus three days of ofloxacin therapy fur travelers' diarrhea: a placebo controlled study. Antimicrob. Agents Chemother. 36:87-91.
4. DuPont, H. L., and C. D. Ericsson. 1993. Prevention and treatment of traveler's diarrhea. N. Engl. J. Med. 328:1821-1826.
5. Ericsson, C. D., P. C. Johnson, H. L. DuPont, D. R. Morgan, J. A. Bitsura, and F. J. Cabada. 1987. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for traveler's diarrhea. Ann. Intern. Med. 106:216-220.
6. Gascón, J., J. Vila, M. E. Valls, L. Ruiz, J. Vidal, M. Corachan, G. Prats, and M. T. Jimenez de Anta. 1993. Etiology of traveler's diarrhea in Spanish travelers to developing countries. Eur. J. Epidemiol. 9:217-223.
7. Gorbach, S. L., B. H. Kean, D. G. Evans, D. J. Evans, Jr., and D. Bessudo. 1975. Traveler's diarrhea and toxigenic Escherichia coli. N. Engl. J. Med. 292:933-936.
8. Merson, M. H., R. B. Sack, S. Islam, G. Saklayen, N. Huda, I. Huq, A. W. Zulich, R. H. Yolken, and A. Z. Kapikian. 1980. Disease due to enterotoxigenic Escherichia coli in Bangladeshi adults: clinical aspects in a controlled trial of tetracycline. J. Infect. Dis. 141:702-711.
9. Murray, B. E., E. R. Rensimer, and H. L. DuPont. 1982. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole. N. Engl. J. Med. 306:130-135.
10. Murray, B. E. 1986. Resistance of Shigella, Salmonella, and other selected enteric pathogens to antimicrobial agents. Rev. Infect. Dis. 8:S172-S181.
11. Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.). 1995. Manual of clinical microbiology, 6th ed. ASM Press. Washington, D.C.
12. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. Approved standard M7-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. Sack, R. B. 1975. Human diarrheal disease caused by enterotoxigenic Escherichia coli. Annu. Rev. Microbiol. 29:333-353.
14. Taylor, D. N., J. L. Sanchez, W. Candler, S. Thornton, C. McQueen, and P. Echevarria. 1991. Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. Ann. Intern. Med. 114:731-734.
15. Vargas, M., J. Gascón, F. Gallardo, M. T. Jimenez de Anta, and J. Vila. 1999. Prevalence of diarrheagenic Escherichia coli strains detected by PCR in patients with traveler's diarrhea. Clin. Microbiol. Infect. 4:682-688.
16. Vila, J., J. Ruiz, F. Marco, A. Barcelo, P. Goñi, E. Giralt, and T. Jimenez de Anta. 1994. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MlCs. Antimicrob. Agents Chemother. 38:2477-2479.
17. Vila, J., J. Ruiz, P. Goñi, and M. T. Jimenez de Anta. 1996. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 40:491-493.
18. Wistrom, J., M. Jertborn, S. A. Hedstrom, K. Alestig, G. Englund, B. Jellheden, and S. R. Norrby. 1989. Short-term self-treatment of travelers' diarrhea with norfloxacin: a placebo controlled study. J. Antimicrob. Chemother. 23:905-913.